Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06081101 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Ketorolac Versus Corticosteroid Injections for Sacroiliac Joint Pain

StatusRecruiting
PhaseEarly Phase 1
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Primary completion moved at least 2 years later Jun 2026 → Jul 2028
See other at-risk trials from McMaster University

Record History

  1. Primary and study completion pushed from Jun 2026 to Jul 2028 Recruitment opened · Start date changed from estimate of Jan 2025 to Mar 1, 2025 · Eligibility criteria expanded, about 16 words · 2 more Show 5 more changesShow less
    • Recruitment opened
    • Start date changed from estimate of Jan 2025 to Mar 1, 2025
    • Eligibility criteria expanded, about 16 words
    • Site details revised
    • Publications: details revised at 15 of 15 entries
  2. Start date: Apr 2024 to Jan 2025v3
  3. Enrollment target: 80 to 20 Start date: Jan 2024 to Apr 2024v2 Show 1 more changeShow less
    • Start date: Jan 2024 to Apr 2024
  4. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
This study will contribute to the current literature that have compared joint injections with steroid versus ketorolac providing evidence for the use of ketorolac for SI joint pain. Currently steroid is the clinical standard for joint injections, however with repetitive use, steroid injections can damage the joint. Ketorolac is an alternative anti-inflammatory medication that does not cause the same joint damage and at a cheaper cost than steroid. The investigators hypothesize that ultrasound guided SI joint injections utilizing ketorolac provide the same pain relief as corticosteroid SI joint injections measured at 2, 6 and 12 weeks post injection. This would allow more frequent injections to control pain at a decreased cost to the healthcare system.
Trial Details
NCT Number NCT06081101
Lead Sponsor McMaster University
Conditions Sacro-iliac Joint Pain
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov